Andrew Feifer

1.9k total citations
49 papers, 1.3k citations indexed

About

Andrew Feifer is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Andrew Feifer has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 21 papers in Surgery and 9 papers in Oncology. Recurrent topics in Andrew Feifer's work include Prostate Cancer Treatment and Research (13 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). Andrew Feifer is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). Andrew Feifer collaborates with scholars based in Canada, United States and Belgium. Andrew Feifer's co-authors include Jacques Corcos, Jennifer M. Taylor, Bernard H. Bochner, William T. Lowrance, Robert J. Downey, Theresa M. Koppie, Elena B. Elkin, Jonathan E. Rosenberg, Franziska Michor and Markus Riester and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Andrew Feifer

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Feifer Canada 20 577 505 191 169 149 49 1.3k
Özdal Dillioğlugil Türkiye 16 792 1.4× 339 0.7× 115 0.6× 163 1.0× 232 1.6× 65 1.2k
Timothy F. Donahue United States 20 1.1k 1.9× 571 1.1× 180 0.9× 453 2.7× 157 1.1× 81 1.8k
Simone Albisinni Belgium 21 865 1.5× 525 1.0× 160 0.8× 311 1.8× 240 1.6× 124 1.6k
Troy Gianduzzo Australia 20 952 1.6× 305 0.6× 114 0.6× 108 0.6× 227 1.5× 55 1.3k
Benjamin J. Davies United States 17 477 0.8× 485 1.0× 185 1.0× 181 1.1× 190 1.3× 64 1.1k
Libni Eapen Canada 24 809 1.4× 703 1.4× 173 0.9× 384 2.3× 60 0.4× 72 1.8k
J.M. Wolff Germany 18 1.3k 2.2× 576 1.1× 206 1.1× 319 1.9× 241 1.6× 93 2.0k
Paul Cathcart United Kingdom 23 1.1k 1.9× 343 0.7× 119 0.6× 204 1.2× 403 2.7× 66 1.5k
Alan M. Nieder United States 23 823 1.4× 1.0k 2.1× 212 1.1× 241 1.4× 235 1.6× 70 1.9k
Francesco Alessandro Mistretta Italy 21 897 1.6× 615 1.2× 242 1.3× 183 1.1× 229 1.5× 124 1.4k

Countries citing papers authored by Andrew Feifer

Since Specialization
Citations

This map shows the geographic impact of Andrew Feifer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Feifer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Feifer more than expected).

Fields of papers citing papers by Andrew Feifer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Feifer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Feifer. The network helps show where Andrew Feifer may publish in the future.

Co-authorship network of co-authors of Andrew Feifer

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Feifer. A scholar is included among the top collaborators of Andrew Feifer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Feifer. Andrew Feifer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niazi, Tamim, Fred Saad, Rashmi Koul, et al.. (2025). Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration resistant prostate cancer: A randomized phase II trial (GROUQ-PCS 9).. Journal of Clinical Oncology. 43(5_suppl). 22–22. 4 indexed citations
2.
Bryant‐Lukosius, Denise, Ricardo Rendon, Alejandro Berlín, et al.. (2023). An Actionable Expert-System Algorithm to Support Nurse-Led Cancer Survivorship Care: Algorithm Development Study. JMIR Cancer. 9. e44332–e44332. 1 indexed citations
3.
Xiong, Ting, Denise Bryant‐Lukosius, Ricardo Rendon, et al.. (2023). A qualitative study on healthcare professional and patient perspectives on nurse-led virtual prostate cancer survivorship care. SHILAP Revista de lepidopterología. 3(1). 159–159. 2 indexed citations
4.
Kwong, Jethro C.C., Adree Khondker, Christopher Tran, et al.. (2022). Explainable artificial intelligence to predict the risk of side-specific extraprostatic extension in pre-prostatectomy patients. Canadian Urological Association Journal. 16(6). 213–221. 8 indexed citations
5.
Khondker, Adree, et al.. (2022). Meningeal metastases in prostate cancer: Institutional series and comprehensive systematic review. Urologic Oncology Seminars and Original Investigations. 41(6). 284–291. 1 indexed citations
6.
Phạm, Quỳnh, Jacqueline L. Bender, Alejandro Berlín, et al.. (2021). Virtual care for prostate cancer survivorship: protocol for an evaluation of a nurse-led algorithm-enhanced virtual clinic implemented at five cancer centres across Canada. BMJ Open. 11(4). e045806–e045806. 8 indexed citations
7.
Phạm, Quỳnh, et al.. (2020). Virtual care models for cancer survivorship. npj Digital Medicine. 3(1). 113–113. 31 indexed citations
8.
Bekelman, Justin E., R. Bryan Rumble, Ronald C. Chen, et al.. (2018). Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline. Journal of Clinical Oncology. 36(32). 3251–3258. 126 indexed citations
9.
Feifer, Andrew, Darren R. Feldman, Brett S. Carver, et al.. (2018). Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) Experience.. Urology. 124. 174–178. 4 indexed citations
10.
Gotto, Geoffrey, Vincent Fradet, Darrel Drachenberg, et al.. (2018). Real-world evidence in patient-related outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate plus prednisone (AA+P).. Journal of Clinical Oncology. 36(6_suppl). 196–196. 3 indexed citations
11.
Bochner, Bernard H., Andrew Feifer, Dahlia Sperling, et al.. (2014). Multi-institutional quality care initiative (QCI) to improve the care of patients with invasive bladder cancer (BlCa).. Journal of Clinical Oncology. 32(4_suppl). 298–298. 6 indexed citations
12.
Silberstein, Jonathan, Preston Sprenkle, Daniel Su, et al.. (2013). Neutrophil gelatinase‐associated lipocalin ( NGAL ) levels in response to unilateral renal ischaemia in a novel pilot two‐kidney porcine model. British Journal of Urology. 112(4). 517–525. 12 indexed citations
13.
Potter, Brian J., Peter Leong‐Sit, Susan M. Fernandes, et al.. (2013). Effect of Aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation. International Journal of Cardiology. 168(4). 3940–3943. 57 indexed citations
14.
Riester, Markus, Jennifer M. Taylor, Andrew Feifer, et al.. (2012). Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder Cancer. Clinical Cancer Research. 18(5). 1323–1333. 177 indexed citations
15.
Taylor, Jennifer M., Andrew Feifer, Caroline Savage, et al.. (2011). Evaluating the utility of a preoperative nomogram for predicting 90‐day mortality following radical cystectomy for bladder cancer. British Journal of Urology. 109(6). 855–859. 25 indexed citations
16.
Feifer, Andrew, Jennifer M. Taylor, Gary D. Steinberg, et al.. (2011). Multi-institutional quality-of-care initiative for nonmetastatic, muscle-invasive, transitional cell carcinoma of the bladder: Phase I.. Journal of Clinical Oncology. 29(7_suppl). 240–240. 34 indexed citations
17.
Feifer, Andrew, Jennifer M. Taylor, Tatum Tarin, & Harry W. Herr. (2011). Maximizing Cure for Muscle-Invasive Bladder Cancer: Integration of Surgery and Chemotherapy. European Urology. 59(6). 978–984. 37 indexed citations
18.
Gallagher, David, Andrew Feifer, & Jonathan Coleman. (2010). Genitourinary Cancer Predisposition Syndromes. Hematology/Oncology Clinics of North America. 24(5). 861–883. 3 indexed citations
19.
Feifer, Andrew, et al.. (2010). 1088 RANDOMIZED CONTROLLED TRIAL OF VIRTUAL REALITY AND HYBRID SIMULATION FOR ROBOTIC SURGICAL TRAINING. The Journal of Urology. 183(4S). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026